Literature DB >> 18954715

Evaluation of four-dimensional computed tomography-based intensity-modulated and respiratory-gated radiotherapy techniques for pancreatic carcinoma.

Ylanga G van der Geld1, Baukelien van Triest, Wilko F A R Verbakel, John R van Sörnsen de Koste, Suresh Senan, Ben J Slotman, Frank J Lagerwaard.   

Abstract

PURPOSE: To compare conformal radiotherapy (CRT), intensity-modulated radiotherapy (IMRT), and respiration-gated radiotherapy (RGRT) planning techniques for pancreatic cancer. All target volumes were determined using four-dimensional computed tomography scans (4D CT). METHODS AND MATERIALS: The pancreatic tumor and enlarged regional lymph nodes were contoured on all 10 phases of a planning 4D CT scan for 10 patients, and the planning target volumes (PTV(all phases)) were generated. Three consecutive respiratory phases for RGRT delivery in both inspiration and expiration were identified, and the corresponding PTVs (PTV(inspiration) and PTV(expiration)) and organ at risk volumes created. Treatment plans using CRT and IMRT, with and without RGRT, were created for each PTV.
RESULTS: Compared with the CRT plans, IMRT significantly reduced the mean volume of right kidney exposed to 20 Gy from 27.7% +/- 17.7% to 16.0% +/- 18.2% (standard deviation) (p < 0.01), but this was not achieved for the left kidney (11.1% +/- 14.2% to 5.7% +/- 6.5%; p = 0.1). The IMRT plans also reduced the mean gastric, hepatic, and small bowel doses (p < 0.01). No additional reductions in the dose to the kidneys or other organs at risk were seen when RGRT plans were combined with either CRT or IMRT, and the findings for RGRT in end-expiration and end-inspiration were similar.
CONCLUSION: 4D CT-based IMRT plans for pancreatic tumors significantly reduced the radiation doses to the right kidney, liver, stomach, and small bowel compared with CRT plans. The additional dosimetric benefits from RGRT appear limited in this setting.

Entities:  

Mesh:

Year:  2008        PMID: 18954715     DOI: 10.1016/j.ijrobp.2008.07.010

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  11 in total

Review 1.  Neoadjuvant radiotherapeutic strategies in pancreatic cancer.

Authors:  Falk Roeder
Journal:  World J Gastrointest Oncol       Date:  2016-02-15

2.  Volumetric modulated arc therapy for advanced pancreatic cancer.

Authors:  Wietse Eppinga; Frank Lagerwaard; Wilko Verbakel; Ben Slotman; Suresh Senan
Journal:  Strahlenther Onkol       Date:  2010-06-24       Impact factor: 3.621

Review 3.  Adjuvant chemoradiation for pancreatic cancer: what does the evidence tell us?

Authors:  Michael D Chuong; Drexell H Boggs; Kruti N Patel; William F Regine
Journal:  J Gastrointest Oncol       Date:  2014-06

4.  Dosimetric and clinical toxicity comparison of critical organ preservation with three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and RapidArc for the treatment of locally advanced cancer of the pancreatic head.

Authors:  L Jin; R Wang; S Jiang; J Yue; T Liu; X Dou; K Zhu; R Feng; X Xu; D Chen; Y Yin
Journal:  Curr Oncol       Date:  2016-02-18       Impact factor: 3.677

5.  Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer.

Authors:  Luciana Caravatta; Giuseppina Sallustio; Fabio Pacelli; Gilbert D A Padula; Francesco Deodato; Gabriella Macchia; Mariangela Massaccesi; Vincenzo Picardi; Savino Cilla; Alfonso Marinelli; Numa Cellini; Vincenzo Valentini; Alessio G Morganti
Journal:  Radiat Oncol       Date:  2012-06-12       Impact factor: 3.481

6.  Bilateral kidney preservation by volumetric-modulated arc therapy (RapidArc) compared to conventional radiation therapy (3D-CRT) in pancreatic and bile duct malignancies.

Authors:  Sabine Vieillot; David Azria; Olivier Riou; Carmen Llacer Moscardo; Jean-Bernard Dubois; Norbert Aillères; Pascal Fenoglietto
Journal:  Radiat Oncol       Date:  2011-10-31       Impact factor: 3.481

7.  4DMRI-based investigation on the interplay effect for pencil beam scanning proton therapy of pancreatic cancer patients.

Authors:  Kai Dolde; Ye Zhang; Naved Chaudhri; Christian Dávid; Marc Kachelrieß; Antony John Lomax; Patrick Naumann; Nami Saito; Damien Charles Weber; Asja Pfaffenberger
Journal:  Radiat Oncol       Date:  2019-02-07       Impact factor: 3.481

8.  Predicting pathological complete response (pCR) after stereotactic ablative radiation therapy (SABR) of lung cancer using quantitative dynamic [18F]FDG PET and CT perfusion: a prospective exploratory clinical study.

Authors:  Dae-Myoung Yang; David A Palma; Keith Kwan; Alexander V Louie; Richard Malthaner; Dalilah Fortin; George B Rodrigues; Brian P Yaremko; Joanna Laba; Stewart Gaede; Andrew Warner; Richard Inculet; Ting-Yim Lee
Journal:  Radiat Oncol       Date:  2021-01-13       Impact factor: 3.481

9.  Development and validation of automatic tools for interactive recurrence analysis in radiation therapy: optimization of treatment algorithms for locally advanced pancreatic cancer.

Authors:  Kerstin A Kessel; Daniel Habermehl; Andreas Jäger; Ralf O Floca; Lanlan Zhang; Rolf Bendl; Jürgen Debus; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2013-06-07       Impact factor: 3.481

10.  The analysis of respiration-induced pancreatic tumor motion based on reference measurement.

Authors:  Lukas Knybel; Jakub Cvek; Bretislav Otahal; Tomas Jonszta; Lukas Molenda; Daniel Czerny; Eva Skacelikova; Marian Rybar; Pavel Dvorak; David Feltl
Journal:  Radiat Oncol       Date:  2014-08-30       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.